COVID-19: NIAID Clinical Research Support Services (CRSS)

国家过敏和传染病研究所（NIAID），国家卫生研究院（NIH），卫生和人类服务部（DHHS）支持与微生物学和免疫学的基本理解相关的研究，从而开发疫苗，治疗和医学诊断，用于预防，治疗和诊断传染病和免疫介导的疾病。该合同的目的是为当前和不断发展的NIAID支持的临床研究组合提供广泛的研究支持服务。该合同使NIAID能够建立和维持促进和推进传染病研究所需的强大和灵活的资源，并建立和维持对高优先级疫苗、其他预防和治疗方法的产品开发活动的支持。将在四个广泛的临床研究领域提供支持：a）临床研究管理; B）临床研究中心协助; c）临床试验管理和d）临床试验合规性。 该项目将为COVID-19 ACTIV 2门诊单克隆抗体和其他疗法临床试验提供支持服务。

The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases. The purpose of this contract is to provide a broad range of research support services to the current and evolving NIAID-supported clinical research portfolio. The contract enables the NIAID to establish and maintain the robust and flexible resources required to facilitate and advance infectious disease research and establish and maintain support for product development activities for high priority vaccine, other prevention and therapeutic approaches. Support will be provided in four broad clinical research areas: a) clinical research management; b) clinical site assistance; c) clinical trial management and d) clinical trial compliance. This project will provide support services for the COVID-19 ACTIV2 Outpatient Monoclonal Antibodies And Other Therapies clinical trial.